FDA May Pull Meridia Diet Drug from Market

The diet pill Meridia could get a new warning label, or it could be pulled from the U.S. market completely, depending on the FDA’s response to their drug advisory committee. Eight committee members voted to pull the drug from the market, but an equal number voted to keep it on the market with new safety restrictions.

The FDA will consider the split decision and decide whether the 16 percent increased risk in major adverse cardiac events caused by the drug is reason enough to restrict access or withdraw the drug from the U.S. market.

ABC News reports:

“Abbot Laboratories products containing Meridia's main ingredient, Sibutramine, were already pulled from the European market in January”.

+ Sources and References
Click Here and be the first to comment on this article
Post your comment